The company
RadNet, Inc.
RDNT · Nasdaq
RDNT stood above a rising 150-day average in 22 of the last 52 weekly readings, including each of the last 9 weeks. It is 10.0% above that average now. Diagnostics & Labs: 52% of its 44 stocks in an uptrend (+2 points in four weeks); Health Care: 27% (−6 points in four weeks).
Statistics
- Last close, 23 Oct 2026
- 70.34 +0.11%
- 52-week range
- —
- Volume
- 0.40M
- Average volume (50 days)
- —
- Relative volume
- —
- Rotation
- Leading
- Weeks in an uptrend
- 9 in a row
- Industry in uptrend
- 52% +2 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $17.1M
- Officials’ trades on record
- 4
- Institutions holding
- 308 (-9)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 22 of 52 weeks.
Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Price and volume
Daily bars to 23 Oct 2026: 30 sessions (1Y reaches back before the first session held here, 11 Sep 2026, so this is all of them). 1D is the last two sessions and 1W the last week of the same daily bars; nothing here is intraday.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
4 disclosed lines: House 0, Senate 0, executive 4; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 30 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 4 Mar 2026filed 14 May 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| David L. SwartzDirector | sold | 2,699at $53.89 | 18 Jun 2026filed 22 Jun 2026 |
| Cornelis WesdorpPres & CEO, Digital Health | sold | 4,750at $58.11 | 16 Jun 2026filed 18 Jun 2026 |
| Stephen M. ForthuberPres & CEO-Eastern Operations | sold | 24,214at $57.79 | 15 Jun 2026filed 16 Jun 2026 |
| Stephen M. ForthuberPres & CEO-Eastern Operations | sold | 19,853at $58.61 | 15 Jun 2026filed 16 Jun 2026 |
| Alma Gregory SorensenChief Strategy Officer | sold | 9,554at $61.84 | 19 Mar 2026filed 23 Mar 2026 |
| Alma Gregory SorensenChief Strategy Officer | sold | 5,346at $62.82 | 19 Mar 2026filed 23 Mar 2026 |
| Alma Gregory SorensenChief Strategy Officer | sold | 100at $63.59 | 19 Mar 2026filed 23 Mar 2026 |
| Alma Gregory SorensenChief Strategy Officer | sold | 14,200at $62.12 | 18 Mar 2026filed 18 Mar 2026 |
| Alma Gregory SorensenChief Strategy Officer | sold | 800at $62.72 | 18 Mar 2026filed 18 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 10,957,808$675.8M | +922,074+9.2% |
| RTW INVESTMENTS, LPadded · filed 14 Aug 2026 | 4,846,958$298.9M | +561,958+13.1% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 4,066,931$250.8M | +167,804+4.3% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,193,565$196.9M | +82,553+2.7% |
| BECK MACK & OLIVER LLCreduced · filed 14 Aug 2026 | 3,163,592$195.1M | -2,600−0.1% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 2,842,457$175.2M | +190,859+7.2% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,858,508$114.6M | +134,901+7.8% |
| Invesco Ltd.added · filed 14 Aug 2026 | 1,641,292$101.2M | +7,797+0.5% |
| AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 2026 | 1,618,424$99.8M | +716,232+79.4% |
| Clearbridge Investments, LLCadded · filed 13 Aug 2026 | 1,546,652$95.4M | +268,112+21.0% |
News
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.